Clinical Trial Project Closure Report
This is a practical guide to building a project closure report for a clinical trial project — the record that formally closes the project and confirms acceptance, adapted to the realities of planning and running a clinical trial.
What a Project Closure Report is
A project closure report is the record that formally closes the project and confirms acceptance. For the full concept and how it works in general, see Project Closure. On a clinical trial project it plays the same role, tuned to this kind of work.
Why it matters for a Clinical Trial project
Clinical Trial projects live or die on planning and running a clinical trial. A well-built project closure report gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how clinical trial projects drift into avoidable delay and cost.
What to include
- Objectives vs outcomes
- Deliverable acceptance
- Budget/schedule summary
- Lessons learned
- Handover
Clinical Trial-specific considerations
Tailor the project closure report to the risks that most often derail clinical trial projects:
- Regulatory and ethics approval
- Patient recruitment
- Data integrity
Example
On a real clinical trial project, the project closure report would be shaped by planning and running a clinical trial. In particular, it should explicitly account for the project’s biggest risks — regulatory and ethics approval, patient recruitment, data integrity — rather than treating them as afterthoughts.